Présidentielles françaises : le Kärcher® de Valérie Pécresse
Dernière ligne droite pour la campagne présidentielle française. L’occasion de revenir sur une déclaration de Valérie Pécresse qui a éveillé notre attention de spécialistes du droit des marques. En campagne
Covid-19 RNA vaccines – a patent dispute.
On March 17, Alnylam Pharmaceuticals has filed infringement suits against Pfizer and Moderna. The concept of vaccination dates from the French Louis Pasteur (nineteenth century), where inactivated virus are
Russian-Ukrainian conflict, what impact on IP rights?
While the conflict between Russia and Ukraine continues, many countries have announced economic sanctions as an alternative to imposing military forces. As a major aspect of any economy, IP
Get to know our IP specialists: 4 questions to our Patent Engineer Alexandre Sylvestre
Alex, could you explain us a bit why you have chosen for the new venture at CALYSTA ? I joined Calysta because I was intrigued how young, dynamic and diverse
Get to know our IP specialists: 4 questions to our Senior Patent Attorney Daisy Bayot
Daisy, could you tell us a bit more about your education, background and experience? My technical background is chemistry. I studied at the UCLouvain where I obtained a bachelor’s
The Unified Patent Court for European patent litigation was born today
The Unified Patent Court for European patent litigation was born today The European Union announced today the entry into force of the Protocol on Provisional Application of the Unified Patent